Diane Young
Equibles does not estimate personal net worth.
About Diane Young
Diane Young has spoken on 1 investor event across 1 company, most recently for Celldex Therapeutics, Inc. on April 14, 2026. The companies whose calls Diane Young spoke on are classified in the Healthcare sector.
Diane Young on recent calls
“So barzavolimab is an anti-KIT monoclonal antibody, and this is a novel mechanism of action that is really targeting the root cause of the disease, the diseases we're dealing with, which is mast cells.”